Literature DB >> 23938379

Effect of zinc and calcium ions on the rat kidney membrane-bound form of dipeptidyl peptidase IV.

Hansel Gómez1, Mae Chappé, Pedro A Valiente, Tirso Pons, María de Los Angeles Chávez, Jean-Louis Charli, Isel Pascual.   

Abstract

Dipeptidyl peptidase IV (DPP-IV) is an ectopeptidase with many roles, and a target of therapies for different pathologies. Zinc and calcium produce mixed inhibition of porcine DPP-IV activity. To investigate whether these results may be generalized to mammalian DPP-IV orthologues, we purified the intact membrane-bound form from rat kidney. Rat DPP-IV hydrolysed Gly-Pro-p-nitroanilide with an average Vmax of 0.86 +/- 0.01 meu mol min-1mL-1 and KM of 76 +/- 6 meu M. The enzyme was inhibited by the DPP-IV family inhibitor L-threo-Ile-thiazolidide (Ki=64.0 +/- 0.53 nM), competitively inhibited by bacitracin (Ki=0.16 +/- 0.01 mM) and bestatin (Ki=0.23 +/- 0.02 mM), and irreversibly inhibited by TLCK (IC50 value of 1.20 +/- 0.11 mM). The enzyme was also inhibited by divalent ions like Zn2+ and Ca2+, for which a mixed inhibition mechanism was observed (Ki values of the competitive component: 0.15 +/- 0.01 mM and 50.0 +/- 1.05 mM, respectively). According to bioinformatic tools, Ca2+ ions preferentially bound to the beta-propeller domain of the rat and human enzymes, while Zn2+ ions to the alpha-beta hydrolase domain; the binding sites were essentially the same that were previously reported for the porcine DPP-IV. These data suggest that the cationic susceptibility of mammalian DPP-IV orthologues involves conserved mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23938379     DOI: 10.1007/s12038-013-9333-8

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  30 in total

1.  WebFEATURE: An interactive web tool for identifying and visualizing functional sites on macromolecular structures.

Authors:  Mike P Liang; D Rey Banatao; Teri E Klein; Douglas L Brutlag; Russ B Altman
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

3.  Predicting calcium-binding sites in proteins - a graph theory and geometry approach.

Authors:  Hai Deng; Guantao Chen; Wei Yang; Jenny J Yang
Journal:  Proteins       Date:  2006-07-01

4.  Effect of divalent cations on the porcine kidney cortex membrane-bound form of dipeptidyl peptidase IV.

Authors:  Isel Pascual; Hansel Gómez; Tirso Pons; Mae Chappé; Miguel Angel Vargas; Gilberto Valdés; Alí Lopéz; Angélika Saroyán; Jean-Louis Charli; María de los Angeles Chávez
Journal:  Int J Biochem Cell Biol       Date:  2010-11-17       Impact factor: 5.085

5.  New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase.

Authors:  T Nagatsu; M Hino; H Fuyamada; T Hayakawa; S Sakakibara
Journal:  Anal Biochem       Date:  1976-08       Impact factor: 3.365

6.  An amphiphilic form of dipeptidyl peptidase IV from pig small-intestinal brush-border membrane. Purification by immunoadsorbent chromatography and some properties.

Authors:  B Svensson; M Danielsen; M Staun; L Jeppesen; O Norén; H Sjöström
Journal:  Eur J Biochem       Date:  1978-10-16

7.  Oral administration of Bis(aspirinato)zinc(II) complex ameliorates hyperglycemia and metabolic syndrome-like disorders in spontaneously diabetic KK-A(y) mice: structure-activity relationship on zinc-salicylate complexes.

Authors:  Yutaka Yoshikawa; Yusuke Adachi; Hiroyuki Yasui; Masakazu Hattori; Hiromu Sakurai
Journal:  Chem Pharm Bull (Tokyo)       Date:  2011       Impact factor: 1.645

8.  Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors.

Authors:  Kenton L Longenecker; Kent D Stewart; David J Madar; Clarissa G Jakob; Elizabeth H Fry; Sherwin Wilk; Chun W Lin; Stephen J Ballaron; Michael A Stashko; Thomas H Lubben; Hong Yong; Daisy Pireh; Zhonghua Pei; Fatima Basha; Paul E Wiedeman; Thomas W von Geldern; James M Trevillyan; Vincent S Stoll
Journal:  Biochemistry       Date:  2006-06-20       Impact factor: 3.162

Review 9.  Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

Authors:  Roger Yazbeck; Gordon S Howarth; Catherine A Abbott
Journal:  Trends Pharmacol Sci       Date:  2009-11       Impact factor: 14.819

10.  Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease.

Authors:  Yusuf Yilmaz; Ozlen Atug; Oya Yonal; Deniz Duman; Osman Ozdogan; Nese Imeryuz; Cem Kalayci
Journal:  Med Sci Monit       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.